Itami Unidie (Diclofenac Sodium)

Diclofenac sodium inhibits cyclooxygenase enzymes (COX‑1 and COX‑2) in the skin and underlying tissues, which reduces the production of prostaglandins that cause inflammation and pain. This localized inhibition leads to decreased swelling and analgesic effects at the site of application.

The specific dose and frequency of Itami Unidie are determined by the prescribing healthcare professional based on the patient’s condition, severity of symptoms, and treatment guidelines. Patients should follow the prescriber’s instructions and the product label.

Safety data for topical diclofenac during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using Itami Unidie.

To order Itami Unidie, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Itami Unidie delivers diclofenac directly to the skin, offering targeted pain relief with lower systemic exposure compared with oral NSAIDs. This can reduce the risk of gastrointestinal side effects while providing effective anti‑inflammatory action for localized conditions.

Store Itami Unidie at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid direct sunlight to maintain stability and efficacy.

Itami Unidie is applied topically to clean, dry skin over the affected area. The prescribed amount is spread in a thin layer and gently massaged until fully absorbed. Hands should be washed after application, and the treated skin should not be covered with occlusive dressings unless directed by a clinician.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and systemic NSAID effects like gastrointestinal bleeding, liver enzyme elevation, or kidney impairment. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, difficulty breathing, or unexplained abdominal pain.

Individuals with known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation should avoid Itami Unidie. It is also contraindicated on broken, infected, or irritated skin, and should be used with caution in patients with a history of cardiovascular, renal, or hepatic disease.